help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ekker, M.
Right arrow Articles by Sourkes, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ekker, M.
Right arrow Articles by Sourkes, T. L.

Endocrinology, Vol 120, 1299-1307, Copyright © 1987 by Endocrine Society

ARTICLES

Decreased activity of adrenal S-adenosylmethionine decarboxylase in rats subjected to dopamine agonists, metabolic stress, or bodily immobilization

M Ekker and TL Sourkes

The activity of S-adenosylmethionine decarboxylase (SAM-DC) has been measured in the adrenal gland of rats given treatments that are known to result in increased activity of ornithine decarboxylase in this organ. In contrast to the effects of the dopamine agonists piribedil and apomorphine on the latter enzyme, the administration of these drugs caused decreases of SAM-DC in both parts of the gland. After piribedil the activity decreased rapidly to a minimum at 2-4 h, with recovery by 6 h. The stress of immobilization or the administration of insulin or 2- deoxyglucose (2-DG) also decreased adrenal SAM-DC activity. The results contrast with those observed in other rat tissues where SAM-DC is generally induced by treatments that induce ornithine decarboxylase. Denervation of the adrenal gland did not clearly affect the reduction in adrenomedullary SAM-DC after 2-DG. Hypophysectomy resulted in reduced SAM-DC activity in both adrenal medulla and cortex; the activity could be restored by giving the animals 2 IU ACTH daily for 4 days. These changes in activity were parallelled by changes in immunoreactive protein. 2-DG did not decrease SAM-DC in hypophysectomized rats receiving maintenance ACTH dosage. This indicates the presence of hormonal control over the activity of SAM-DC in the adrenal medulla and cortex. Acute administration of an additional 10 IU ACTH to hypophysectomized rats on maintenance dosage of ACTH resulted in decreased SAM-DC activity in both adrenal medulla and cortex. These decreases were not abolished by inhibition of corticosteroid synthesis with metopirone. PRL and GH had no significant effect on adrenal SAM-DC activity of hypophysectomized rats. The reduction of SAM-DC activity in both parts of the gland of hypophysectomized rats with administration of (Bu)2cAMP suggests that cAMP may mediate the decreases in SAM-DC caused by the above treatments.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society